Skip to content

Biz News Today

Business News – Direct Source News

  • Home
  • Business News Videos
    • International/National News Videos
  • Directory
  • Links PRs
  • REITS
  • About
  • Contact
    • Sitemap

Bristol Myers Squibb and bluebird bio Announce Submission of Biologics License Application (BLA) to FDA for Idecabtagene Vicleucel (Ide-cel, bb2121) for Adults with Relapsed and Refractory Multiple Myeloma

  • Home
  • 2020
  • July
  • 29
  • Bristol Myers Squibb and bluebird bio Announce Submission of Biologics License Application (BLA) to FDA for Idecabtagene Vicleucel (Ide-cel, bb2121) for Adults with Relapsed and Refractory Multiple Myeloma

Original Source

On July 29, 2020

Post navigation

Previous PostNorwegian Cruise Line Puts Guests First With Extended Peace of Mind Cancellation Policy and Final Payment Schedule
Next PostBristol Myers Squibb Board Elects Two New Independent Directors

Related Post

August 16, 2022
  • Business News

More than 1,800 customers in Texas assisted through Entergy’s The Power to Care program

August 16, 2022
  • Business News

Modification to Methodology of the S&P/CLX INTER

August 16, 2022
  • Business News

HII CEO Tours Company Operations in Hawaii and Meets with Military and Civilian Leaders

Copyright © All right reserved
Newslist Created By Rise Themes

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219